Effect of Carbamazepine on the Pharmacokinetics (PK) of AT-527

NCT04784000 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer Study

Interventions

DRUG: Period 1: AT-527 550 mg
DRUG: Period 2: carbamazepine
DRUG: Period 3: AT-527 550 mg + carbamazepine
DRUG: Period 3: AT-527 1100 mg + carbamazepine

Sponsor

Atea Pharmaceuticals, Inc.

Collaborators

[object Object]